Why The FDA's Approval Of A New Alzheimer's Drug Should Worry You

Aduhelm, a pricey treatment meant to stall mental decline, may be a case study in everything that's wrong with how America manages prescription drugs.

Source: Science - The Huffington Post - June 16, 2021 Category: Science Source Type: news